Curious about the ENA device?

Enphasys are very excited to have had the great opportunity to publish a short commination in the CRS India Local Chapter Newsletter about our patented ENA device, evaluating the digestion-release and permeation of various advanced drug delivery systems. The communications sum up the important findings made in several studies, in the effort of developing better, more predictive in vitro testing of complex formulations. You can find the complete publication here on pages 19-21:

Enphasys recipient of brand new EU Initiative for Deep-Tech startups

Deep tech innovations are a significant part of Europe’s start-up ecosystem, and target for a range of EU Initiatives. Women TechEU is a brand new initiative of the European Union, supporting women-led deep-tech start-ups. Out of a large number of applicants, Enphasys was selected as one out of 50 promising startups. The support is directed towards Enphasys work of developing new absorption models for sustainable and animal-free screening of pharmaceutical formulations intended for oral use. Read the full announcement here:

Meet Anton Norberg – Enphasys first project student

Enphasys believe in taking part in education, and involving students in our work. Anton Norberg, studying the Master of Science program in Pharmacy at Uppsala University, will do his project work with us, and will be a great addition to the team. He already has a significant experimental experience from working in other research projects within the industrial and academic sector and work at a Covid-19 diagnostic lab. His project will focus on developing new in vitro models to evaluate the performance of complex drug delivery systems. Very welcome to the team Anton!

Enphasys is growing – Meet Dr Daniel Bergström

During autumn, a new team member joined Enphasys – Dr Daniel Bergström, our Business Development Manager. Apart from having a PhD in Medical Science from Uppsala University, Dr. Bergström holds a Master of business administration (MBA) from Edinburgh Business School. He has significant experience from national and international positions within medical science and medical affairs in the pharmaceutical, as well as the medical nutrition industry. At Enphasys, he will lead the work on business development and communication strategies.

Enphasys securing patent

Enphasys have now been granted an European patent for our in vitro intestinal drug disposition device. The device have shown to accurately predict the in vivo performance of lipid-based formulations in several different species, due to presence of an absorption chamber. We are looking forward to make this promising technology available for formulators around the world.

Further reading can be found here:

The intestinal absorption device

Meet our newest employee

We are happy to announce that Dr. Caroline Alvebratt joined the Enphasys team during the spring. Caroline has a strong background in the pharmaceutical field and after receiving her pharmacist license, she persuade a PhD in pharmaceutical science. Her thesis focused poorly water-soluble compounds and making use of advanced drug delivery systems to improve their performance. A major part of her thesis work was also directed towards development of efficient in vitro models for the complex drug formulations. Caroline will assist with the experimental work and costumer interactions.

Enphasys received Attractive Innovation Project 2019 Award

15 projects run by, or in collaboration with, Uppsala University researchers and students have been acknowledged with the 2019 “Attractive Innovation Project” award. Common to all projects is support från Uppsala University Innovation and success in securing external funding to further enhance development opportunities.


Commercialization journey of Enphasys: something to digest

Entrepreneurship in academic setting – Nordic POP workshop
Time: May 9-10, 2019 (lunch-to-lunch meeting)
Place: Copenhagen

Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro

We have recently published a paper about our lipolysis-permeation setup (ENA) which accurately predict the performance of lipid-based formulations in pigs. Here is a link to the article published in Molecular Pharmaceutics:

Video published from the UIC day pitch

Janneke Keemink at Enphasys pitching on the UIC Day 2018.